课题基金 / 基金详情

The early development of leptin and adiponectin resistance in skeletal muscle - a possible protective mechanism

The early development of leptin and adiponectin resistance in skeletal muscle - a possible protective mechanism
骨骼肌中瘦素和脂联素抵抗的早期发展——一种可能的保护机制
批准号:
217437-2011
负责人:
Dyck, David
金额:
$2.26万
依托单位:
依托单位国家:
加拿大
项目类别:
Discovery Grants Program - Individual
财政年份:
2014
资助国家:
加拿大
项目状态:
已结题
起止时间:
2014-01-01 至 2015-12-31

项目摘要

项目成果

Dyck, David的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Leptin and adiponectin are adipokines that improve insulin response in skeletal muscle, an effect attributed to their ability to stimulate fatty acid (FA) oxidation and decrease lipid accumulation. Conditions in which insulin resistance occurs, such as obesity, are characterized by a resistance to the stimulatory effects of leptin and adiponectin on FA oxidation. Resistance to these adipokines can be induced within days of administering a high fat diet, and precedes intramuscular lipid accumulation and impaired insulin response. Thus, it is tempting to speculate that the rapid development of resistance to these adipokines is an initiating event in the early development of impaired insulin signalling in muscle. However, findings of recent studies have challenged the dogma that impaired mitochondrial FA oxidation is the cause of impaired insulin response in muscle. Others have hypothesized that an excessive rate of FA ß-oxidation secondary to increased lipid availability may generate various deleterious species, such as reactive oxygen species (ROS), which can potentially damage many cellular proteins including those of the insulin signalling cascade. Notably, ROS are elevated in muscle after only 3 days of high fat feeding. It is our view that the rapid development of leptin and adiponectin resistance during the administration of a high fat diet is not the cause of impaired insulin signalling, but rather a protective mechanism to limit excessive FA entry into the mitochondrion and subsequent ROS production. The following series of experiments will test our general working hypothesis that ROS production is an important controller of leptin and adiponectin's ability to stimulate mitochondrial FA uptake.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of peripheral metabolism by ghrelin.
  • 批准号:
    RGPIN-2022-03425
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.04万
  • 财政年份:
    2022
  • 负责人:
    Dyck, David
  • 依托单位:
The metabolic effects of ghrelin on muscle, adipose and liver.
  • 批准号:
    RGPIN-2016-03908
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2021
  • 负责人:
    Dyck, David
  • 依托单位:
The metabolic effects of ghrelin on muscle, adipose and liver.
  • 批准号:
    RGPIN-2016-03908
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2020
  • 负责人:
    Dyck, David
  • 依托单位:
The metabolic effects of ghrelin on muscle, adipose and liver.
  • 批准号:
    RGPIN-2016-03908
  • 项目类别:
    Discovery Grants Program - Individual
  • 资助金额:
    $2.99万
  • 财政年份:
    2019
  • 负责人:
    Dyck, David
  • 依托单位:
国内基金
海外基金
损伤线粒体传递机制介导成纤维细胞/II型肺泡上皮细胞对话在支气管肺发育不良肺泡发育阻滞中的作用
  • 批准号:
    82371721
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    王星云
  • 依托单位:
增强子在小鼠早期胚胎细胞命运决定中的功能和调控机制研究
  • 批准号:
    82371668
  • 项目类别:
    面上项目
  • 资助金额:
    52.00万元
  • 批准年份:
    2023
  • 负责人:
    乔云波
  • 依托单位:
MAP2的m6A甲基化在七氟烷引起SST神经元树突发育异常及精细运动损伤中的作用机制研究
  • 批准号:
    82371276
  • 项目类别:
    面上项目
  • 资助金额:
    47.00万元
  • 批准年份:
    2023
  • 负责人:
    严佳
  • 依托单位:
"胚胎/生殖细胞发育特性激活”促进“神经胶质瘤恶变”的机制及其临床价值研究
  • 批准号:
    82372327
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    马展
  • 依托单位: